Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.

Publication Type:

Journal Article

Source:

Journal of acquired immune deficiency syndromes (1999) (2013)

Keywords:

2013, November 2013, Public Health Sciences Division, Vaccine and Infectious Disease Division

Abstract:

HPTN 046 compared the efficacy and safety of infant nevirapine (NVP) among HIV-exposed breastfed infants randomized at 6 weeks to 6 months to t NVP or placebo to prevent postnatal infection: we report final 18 month outcomes.